Gamal Esmat
Top View
- Effectiveness of Ravidasvir Plus Sofosbuvir in Interferon-Naïve and Treated Patients with Chronic Hepatitis C Genotype-4
- Brief Resume
- Chronic Hepatitis E Virus Infection by Support*K\YPUN[O Froml03 EASL*PU3 Andvukvu ELPA.9LJLU[S` -\Y[OLYPUMVYTH[PVUYLNHYKPUN03* >Yprofs\YX^Y -V
- Prof. Gamal Esmat How to Treat HCV in a Resource-Limited Setting the Success Story in Egypt
- Effectiveness of Ravidasvir Plus Sofosbuvir in Interferon-Naã¯Ve And
- Prof. Gamal Esmat HCV Treatment in the Era of DAA the Egyptian
- Ledipasvir/Sofosbuvir with Or Without Ribavirin for 8 Or 12 Weeks For
- Ombitasvir, Paritaprevir, and Ritonavir Plus Ribavirin for Chronic Hepatitis C
- Generic Daclatasvir Plus Sofosbuvir, with Or Without Ribavirin, in Treatment of Chronic Hepatitis C: Real-World Results from 18 378 Patients in Egypt
- WGO Practice Guidelines Style Template
- Program Evaluation Screening and Treatment Program to Eliminate Hepatitis C in Egypt 19 Mar 2020
- How to Optimize Hepatitis C Virus Treatment Impact on Life Years Saved in Resource-Constrained Countries
- Hepatitis C Guideline
- HCV AASLD-2015-Lakebreakingabstracts
- Real Life Egyptian Experience of Efficacy and Safety of Simeprevir&
- Accelerating Access to Hepatitis C Diagnostics and Treatment